Back to

Miss Georgia McCaughan

Senior Research Associate

BMedSc MBBS (University Medal) MMed (Clin Epi) FRACP FRCPA

Medicine & Health

School of Clinical Medicine

Specialties
Clinical and Laboratory Haematology

Department
Haematology

Areas of Interest
Plasma cell disorders including multiple myeloma and AL amyloidosis

Roles
Staff Specialist Haematologist, St Vincent’s Public Hospital 

VMO Haematologist, St Vincent’s Private Hospital 

Senior Research Associate, University of New South Wales

Phone

02 9355 5656

Location

The Kinghorn Cancer Centre, 370 Victoria Street, Darlinghurst. NSW 2010

Journal articles | 2025

Chadwick V; Mills G; Tang C; Anazodo A; Dear R; Rogers R; Lavee O; Milliken S; McCaughan G; Hamad N, 2025, 'Rates of Fertility Discussions and Counseling Before, During, and After Anticancer Treatments', JNCCN Journal of the National Comprehensive Cancer Network, 23, pp. 21 - 26, http://dx.doi.org/10.6004/jnccn.2024.7068

Journal articles | 2025

Gorrie N; Geenty P; Rye E; Sivasubramaniam V; Carroll A; McCaughan G; Thomas L; Fatkin D; Bart N, 2025, 'Atrial cardiomyopathy in cardiac amyloidosis: clinical imaging and manifestations', npj Cardiovascular Health, 2, http://dx.doi.org/10.1038/s44325-025-00043-z

Journal articles | 2025

Lim KJC; Wellard C; Moore E; Ninkovic S; Chng WJ; Spencer A; Mollee P; Hocking J; Ho PJ; Janowski W; Kim K; McCaughan G; Dun K; McQuilten ZK; Chen F; Quach H, 2025, 'Presence of 1q21 Gain and Amplification May be Associated With Poorer Outcomes in Daratumumab-treated Multiple Myeloma Patients', Clinical Lymphoma, Myeloma and Leukemia, 25, pp. 243 - 248, http://dx.doi.org/10.1016/j.clml.2024.11.002

Journal articles | 2025

Sandhu G; Adattini J; Armstrong Gordon E; O'Neill N; Bagnis C; Boddy AV; Chambers P; Flynn A; Hamilton B; Ibrahim K; Johnson DW; Karapetis C; Kelly A; Kerr KA; Kichenadasse G; Kliman DS; Kurkard C; Liauw W; Lucas C; Mallett AJ; Malyszko J; McCaughan G; Michael M; Mirkov S; Morris E; Pollock CA; Roberts DM; Routledge DJ; Scuderi C; Shingleton J; Shortt J; Siderov J; Sprangers B; Stein BN; Tey A; Webber K; Wichart J; Wong R; Ward RL, 2025, 'Integrating International Consensus Guidelines for Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) into everyday practice', eClinicalMedicine, http://dx.doi.org/10.1016/j.eclinm.2025.103161

Journal articles | 2024

Chai KL; Wellard C; Thao L; Aoki N; Moore EM; Augustson BM; Bapat A; Blacklock H; Chng WJ; Cooke R; Forsyth CJ; Goh Y-T; Hamad N; Harrison SJ; Ho PJ; Hocking J; Kerridge I; Kim JS; Kim K; King T; McCaughan GJ; Mollee P; Morrissey CO; Murphy N; Quach H; Tan XN; Tso AC; Wong KS; Yoon S-S; Spencer A; Wood EM; McQuilten ZK, 2024, 'Variation in immunoglobulin use and impact on survival in myeloma.', EJHaem, 5, pp. 690 - 697, http://dx.doi.org/10.1002/jha2.938

Journal articles | 2024

Gorrie N; Montgomery E; Kessler C; Fatkin D; Hayward C; Macdonald P; Jabbour A; Kotlyar E; Muthiah K; McCaughan G; S. A; Bart NK, 2024, 'Cardiac transplantation for transthyretin amyloidosis (ATTR): A single centre experience PB152 (#446)', , http://dx.doi.org/10.26226/m.65f9bf8be6f73964e1d4f5b7

Journal articles | 2024

Gorrie N; Montgomery E; Kessler C; Fatkin D; McCaughan G; Bart NK; Carroll A, 2024, 'Diagnosing Transthyretin Amyloidosis: A single centre experience with histopathological diagnosis PB91 (#553)', , http://dx.doi.org/10.26226/m.65f9bf8be6f73964e1d4f944

Journal articles | 2024

Gorrie N; Montgomery E; Kessler C; Fatkin D; S. A; McCaughan G; Bart NK, 2024, 'Cardiac Magnetic Resonance Imaging for the early diagnosis of AL cardiomyopathy: A case series PB128 (#445)', , http://dx.doi.org/10.26226/m.65f9bf8be6f73964e1d4f5b4

Journal articles | 2024

Gorrie N; Montgomery E; Kessler Iglesias C; Fatkin D; Carroll A; McCaughan G; Bart N, 2024, 'The Role of Cardiac Magnetic Resonance Imaging for Cardiac Staging of AL Amyloidosis', Heart, Lung and Circulation, 33, pp. S291 - S292, http://dx.doi.org/10.1016/j.hlc.2024.06.360

Journal articles | 2024

Gration B; Wellard C; Moore E; Mollee P; Kerridge IH; Spencer A; Shetty A; Baker B; Forsyth C; Heenan J; McQuilten ZK; Wood EM; McCaughan G, 2024, 'Impact of Socioeconomic Status on Utilisation of ASCT and Overall Survival in Multiple Myeloma: A Report from the Australian and New Zealand (ANZ) Myeloma and Related Diseases Registry (ANZ MRDR)', Blood, 144, pp. 5147 - 5147, http://dx.doi.org/10.1182/blood-2024-199451

Journal articles | 2024

Gration B; Wellard C; Moore E; Tan M; Murphy M; Lim KJC; Rowland J; Hamad N; Rajagopal R; Mollee P; Spencer A; Quach H; McCaughan G, 2024, 'Treatment of First Relapse of Multiple Myeloma in Australia and New Zealand (ANZ): Treatment Patterns and Outcomes: An ANZ Myeloma and Related Diseases Registry (ANZ MRDR) Analysis', Blood, 144, pp. 2385 - 2385, http://dx.doi.org/10.1182/blood-2024-201790

Journal articles | 2024

Hoff FW; Banerjee R; Khan AM; McCaughan G; Wang B; Wang X; Roose J; Anderson LD; Cowan AJ; Rajkumar SV; Kaur G, 2024, 'Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis', Blood Cancer Journal, 14, http://dx.doi.org/10.1038/s41408-024-01034-6

Journal articles | 2024

Irving A; Petrie D; Harris A; Fanning L; Wood EM; Moore E; Wellard C; Waters N; Huynh K; Augustson B; Cook G; Gay F; McCaughan G; Mollee P; Spencer A; McQuilten ZK, 2024, 'Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registry', PLoS ONE, 19, http://dx.doi.org/10.1371/journal.pone.0308812

Journal articles | 2024

Lim KJC; Wellard C; Moore E; Gration B; Augustson B; Mollee P; Zhang J; Wong Doo N; Ringkowski S; Bryant A; Ninkovic S; Hamad N; McCaughan G; Kumar S; Spencer A; Quach H, 2024, 'Integrating Chromosomal 1 Abnormalities into the Definition of High-Risk Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry', Blood, 144, pp. 1951 - 1951, http://dx.doi.org/10.1182/blood-2024-207609

Journal articles | 2024

Montgomery E; Gorrie N; Rye E; Kessler C; Fatkin D; Macdonald P; S. A; McCaughan G; Bart NK, 2024, 'The prevalence of frailty and association with disease severity in transthyretin amyloid cardiomyopathy PC40 (#265)', , http://dx.doi.org/10.26226/m.65f9bf8ae6f73964e1d4f00f

Journal articles | 2024

Montgomery E; Gorrie N; Rye E; Kessler Iglesias C; Fatkin D; Carroll A; McCaughan G; Bart N, 2024, 'The Role of Specialist Nursing Education in a Hybrid Multidisciplinary Amyloidosis Clinic', Heart, Lung and Circulation, 33, pp. S330 - S330, http://dx.doi.org/10.1016/j.hlc.2024.06.446

Journal articles | 2024

Montgomery E; Gorrie N; Rye E; Kessler Iglesias C; Fatkin D; Macdonald P; Carroll A; McCaughan G; Bart N, 2024, 'Frailty Prevalence and Characteristics in a Transthyretin Amyloid Cardiomyopathy Cohort', Heart, Lung and Circulation, 33, pp. S131 - S131, http://dx.doi.org/10.1016/j.hlc.2024.06.023

Journal articles | 2023

Banerjee R; Kaur G; Wang B; Larry AD; McCaughan G; Cowan AJ; Rajkumar V, 2023, 'Standard-of-Care Bortezomib Dosing in Multiple Myeloma: An International Survey of Physicians', BLOOD, 142, http://dx.doi.org/10.1182/blood-2023-173772

Journal articles | 2023

Banerjee R; Wang B; Anderson LD; McCaughan G; Mehra N; Cowan AJ; Rajkumar SV; Kaur G, 2023, 'Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians', Blood Cancer Journal, 13, http://dx.doi.org/10.1038/s41408-023-00937-0

Journal articles | 2023

Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; McCaughan G; Moore J; Withers B; Hamad N, 2023, 'Rates of Menstrual History-Taking and Counseling With Anticancer Treatments Are Low: People Who Menstruate Deserve Gender-Specific Cancer Care', JNCCN Journal of the National Comprehensive Cancer Network, 21, pp. 366 - 372, http://dx.doi.org/10.6004/jnccn.2022.7255

Journal articles | 2023

Hoff FW; Banerjee R; Khan A; McCaughan G; Wang XW; Roose J; Anderson LD; Cowan AJ; Rajkumar V; Kaur G, 2023, 'Retrospective Observational Study on Real-World Bortezomib Prescribing Patterns and Outcomes in Newly Diagnosed Multiple Myeloma', Blood, 142, pp. 544 - 544, http://dx.doi.org/10.1182/blood-2023-178950

Journal articles | 2023

Lasica M; Spencer A; Horvath N; Janowski W; Coghlan D; Wallington-Gates C; Campbell P; Lai HC; McCaughan G; Weber N; Puliyayil A; Wong P; Yachao D; Le K; Reynolds J; Quach H, 2023, 'A Phase I/II Single Arm Study of Belantamab Mafodotin, Carfilzomib and Dexamethasone in Patients with Relapsed Multiple Myeloma: Planned Interim Analysis of Safety and Efficacy. Amarc 19-02 Belacard Study', Blood, 142, pp. 2012 - 2012, http://dx.doi.org/10.1182/blood-2023-189005

Journal articles | 2023

Moore E; Harrison S; Ho PJ; Irving A; King T; McCaughan G; McQuilten Z; Mollee P; Park S; Petrie D; Reynolds J; Rutherford C; van Tonder T; Wellard C; Wood E; Spencer A, 2023, 'P-476 More efficient delivery of high-cost standard-of-care therapies in relapsed multiple myeloma using real-time feedback of patient-reported outcome measures: the MY-PROMPT-2 trial', Clinical Lymphoma Myeloma and Leukemia, 23, pp. S301 - S302, http://dx.doi.org/10.1016/s2152-2650(23)02093-1

Journal articles | 2023

Moore E; Harrison S; Ho PJ; Irving A; King T; Mccaughan G; Mcquilten Z; Mollee P; Park S; Petrie D; Reynolds J; Rutherford C; van Tonder T; Wellard C; Wood E; Spencer A, 2023, 'PB2698: MORE EFFICIENT DELIVERY OF HIGH-COST STANDARD-OF-CARE THERAPIES IN RELAPSED MULTIPLE MYELOMA USING REAL-TIME FEEDBACK OF PATIENT-REPORTED OUTCOME MEASURES: THE MY-PROMPT-2 TRIAL', HemaSphere, 7, pp. e68933f0 - e68933f0, http://dx.doi.org/10.1097/01.hs9.0000977464.68933.f0

Journal articles | 2023

Quach H; Lasica M; Low M; Mollee P; Lai HC; Doo NW; Hocking J; Campbell P; Murphy NE; Sidiqi MH; Routledge D; Heenan J; Horvath N; Eek R; Renwick WEP; Lenton DS; Child LJ; McCaughan G; Butcher BE; Mazumdar D; Kalff A, 2023, 'Planned Interim Safety Analysis of the Phase 3 Randomized Trial of Selinexor and Lenalidomide Versus Lenalidomide Maintenance Post Autologous Stem Cell Transplant for Patients with Newly Diagnosed Multiple Myeloma (ALLG MM23; Sealand)', BLOOD, 142, http://dx.doi.org/10.1182/blood-2023-185169

Journal articles | 2023

Rajasekariah H; McCaughan G; Ma CKK; Gorrie N; Milliken S; Ma D; Fay K; Withers B; Hamad N; Birch S; Keogh A; Jabbour A; Hayward C; Macdonald P; Moore J, 2023, 'Orthotopic Heart Transplantation Followed By Autologous Stem Cell Transplantation in Patients with Cardiac AL Amyloidosis: Results from a Single Centre Prospective Study', BLOOD, 142, http://dx.doi.org/10.1182/blood-2023-184319

Journal articles | 2022

Chai KL; Wellard C; Aoki N; Moore EM; Augustson B; Bapat A; Blacklock HA; Chng WJ; Cooke R; Forsyth C; Hamad N; Harrison SJ; Ho PJ; Hocking J; Kerridge IH; Kim JS; Kim K; King T; McCaughan GJ; Mollee P; Morrissey CO; Murphy N; Quach H; Tan XN; Tso A; Wong K; Spencer A; Wood EM; McQuilten ZK, 2022, 'P1573: VARIATION IN USE OF IMMUNOGLOBULIN AND IMPACT ON SURVIVAL IN MULTIPLE MYELOMA: A REPORT FROM THE AUSTRALIA/NEW ZEALAND (ANZ) AND ASIA-PACIFIC (APAC) MYELOMA AND RELATED DISEASES REGISTRIES (MRDR)', HemaSphere, 6, pp. 1454 - 1455, http://dx.doi.org/10.1097/01.hs9.0000849148.93868.54

Journal articles | 2022

Jiang W; Clancy LE; Avdic S; Sutrave G; Street J; Simms R; McGuire HM; Patrick E; Chan AS; McCaughan G; Myers N; Micklethwaite KP; Antonenas V; Selim AG; Ritchie D; Bateman CM; Shaw PJ; Blyth E; Gottlieb DJ, 2022, 'Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant', Blood Advances, 6, pp. 4949 - 4966, http://dx.doi.org/10.1182/bloodadvances.2022007103

Journal articles | 2022

Lasica M; Spencer A; Campbell P; Wallington-Gates C; Doo NW; Janowski W; McCaughan G; Puliyayil A; Yuen F; Le K; Reynolds J; Quach H, 2022, 'OAB-048: An interim analysis of a phase I/II single arm study of belantamab mafodotin, carfilzomib and dexamethasone in patients with relapsed multiple myeloma: AMaRC 19-02 BelaCarD study', Clinical Lymphoma Myeloma and Leukemia, 22, pp. S29 - S30, http://dx.doi.org/10.1016/s2152-2650(22)00321-4

Journal articles | 2022

Lasica M; Spencer A; Campbell P; Wallington-Gates C; Wong Doo N; Janowski W; McCaughan G; Puliyayil A; Yuen F; Le K; Reynolds J; Quach H, 2022, 'P946: A PHASE I/II SINGLE ARM STUDY OF BELANTAMAB MAFODOTIN, CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: AMARC 19-02 BELACARD STUDY.', HemaSphere, 6, pp. 836 - 837, http://dx.doi.org/10.1097/01.hs9.0000846652.51254.ac

Journal articles | 2022

McCaughan GJ; Gandolfi S; Moore JJ; Richardson PG, 2022, 'Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review', British Journal of Haematology, 199, pp. 190 - 204, http://dx.doi.org/10.1111/bjh.18295

Journal articles | 2022

Withers B; McCaughan G; Hayward C; Kotlyar E; Jabbour A; Rainer S; De Angelis E; Horvath N; Milliken S; Dogan A; MacDonald P; Moore J, 2022, 'Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort', Internal Medicine Journal, 52, pp. 69 - 78, http://dx.doi.org/10.1111/imj.15072

Journal articles | 2021

Bishop DC; Clancy LE; Simms R; Burgess J; Mathew G; Moezzi L; Street JA; Sutrave G; Atkins E; McGuire HM; Gloss BS; Lee K; Jiang W; Maddock K; McCaughan G; Avdic S; Antonenas V; O'Brien TA; Shaw PJ; Irving DO; Gottlieb DJ; Blyth E; Micklethwaite KP, 2021, 'Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells', Blood, 138, pp. 1504 - 1509, http://dx.doi.org/10.1182/blood.2021010813

Journal articles | 2021

Chadwick VL; Mills G; Di Ciaccio PR; Tang C; Dear R; Moore J; Milliken S; Withers B; Lavee O; McCaughan GJ; Perram J; Hamad N, 2021, 'A Minority of Women of Child Bearing Potential Are Tested for Pregnancy before Chemoimmunotherapy: An Australian Cancer Centre Experience', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-154028

Journal articles | 2021

Hung D; Lenton D; Eslick R; Blennerhassett R; Joshi M; McCaughan G; Day S; Wright D, 2021, 'Chromosome microarray characterisation of chromosome arm 12p loss associated with complex molecular karyotype and recurrent adverse cytogenetic markers in multiple myeloma', Genes Chromosomes and Cancer, 60, pp. 668 - 677, http://dx.doi.org/10.1002/gcc.22975

Journal articles | 2021

Li Chai K; Wellard C; Moore EM; Augustson B; Bapat A; Blacklock HA; Cooke RE; Forsyth C; Hamad N; Harrison SJ; Ho PJ; Hocking J; Kerridge IH; King T; McCaughan GJ; Mollee P; Morrissey O; Murphy NE; Quach H; Tan XN; Wong K; Spencer A; Wood EM; McQuilten Z, 2021, 'Variation in Use of Immunoglobulin and Impact on Survival in Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-147622

Journal articles | 2021

McCaughan G; Di Ciaccio P; Ananda-Rajah M; Gilroy N; MacIntyre R; Teh B; Weinkove R; Curnow J; Szer J; Enjeti AK; Ross DM; Mulligan S; Trotman J; Dickinson M; Quach H; Choi P; Polizzotto MN; Tam CS; Ho PJ; Ku M; Gregory G; Gangatharan S; Hapgood G; Cochrane T; Cheah C; Gibbs S; Wei A; Johnston A; Greenwood M; Prince HM; Latimer M; Berkahn L; Wight J; Armytage T; Hamad N, 2021, 'COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement', Internal Medicine Journal, 51, pp. 763 - 768, http://dx.doi.org/10.1111/imj.15247

Journal articles | 2021

McCaughan G; Jarvis S; Joseph J, 2021, 'Abnormal coagulation profiles in monoclonal gammopathy of undetermined significance: a case series', Pathology, 53, pp. 798 - 800, http://dx.doi.org/10.1016/j.pathol.2020.11.005

Journal articles | 2021

McCaughan G; Ma D; Moore J, 2021, 'Two cases of successful autologous stem cell transplantation in patients with multiple myeloma and concurrent chronic myeloid leukaemia', Bone Marrow Transplantation, 56, pp. 514 - 516, http://dx.doi.org/10.1038/s41409-020-01025-8

Journal articles | 2021

McCaughan GJ; Tran S; Durrant S; Harrison S; Morton J; Horvath N; Spencer A; Kerridge IH; Ke Er JA; Barge L; Bryant A; Filshie R; Choong E; Lai HC; Tiley C; Mills A; Butler A; Moore J; Hertzberg M; Kennedy G; Ho PJ; Sidiqi MH; Bashford J; Routledge D; Taylor K; Lee C; Kalff A; Xia W; Hamad N, 2021, 'Trends and Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study', Transplantation and Cellular Therapy, 27, pp. S399 - S401, http://dx.doi.org/10.1016/s2666-6367(21)00515-7

Journal articles | 2021

McCaughan GJ; Verma A; Ling S; Lavee O; Moore JJ; Bryant A, 2021, 'Weekly cyclophosphamide, subcutaneous bortezomib and dexamethathasone (CyBorD) for initial treatment of transplant-eligible patients with multiple myeloma: experience of two transplant centres', Bone Marrow Transplantation, 56, pp. 738 - 740, http://dx.doi.org/10.1038/s41409-020-01086-9

Journal articles | 2021

Mills G; Tang C; Di Ciaccio PR; Chadwick VL; Withers B; Lavee O; Milliken S; Perram J; McCaughan GJ; Hamad N, 2021, 'Systematic Omission of Pregnant and Lactating Women from Malignant Haematology Trials Perpetuates a Cycle of Exclusion, Data Shortage and Disadvantage', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-149354

Journal articles | 2020

Di Ciaccio P; McCaughan G; Trotman J; Ho PJ; Cheah CY; Gangatharan S; Wight J; Ku M; Quach H; Gasiorowski R; Polizzotto MN; Prince HM; Mulligan S; Tam CS; Gregory G; Hapgood G; Spencer A; Dickinson M; Latimer M; Johnston A; Armytage T; Lee C; Cochrane T; Berkhahn L; Weinkove R; Doocey R; Harrison SJ; Webber N; Lee HP; Chapman S; Campbell BA; Gibbs SDJ; Hamad N, 2020, 'Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic', Internal Medicine Journal, 50, pp. 667 - 679, http://dx.doi.org/10.1111/imj.14859

Journal articles | 2020

McCaughan GJ; Crowther HJ; Chen V; Chunilal SD; Merriman E; Bortz H; Young L; Tran HA; Yuen HLA; Curnow J, 2020, 'Australian and New Zealand Registry of Anticoagulation in the Obese: Prescribing Patterns, Drug Levels and Patient Outcomes', BLOOD, 136, http://dx.doi.org/10.1182/blood-2020-143150

Journal articles | 2020

McCaughan GJ; Tran S; Durrant S; Harrison SJ; Morton J; Horvath N; Spencer A; Kerridge IH; Er JAK; Barge L; Bryant A; Filshie RJ; Choong E; Lai HC; Tiley C; Mills AK; Butler A; Moore J; Hertzberg M; Kennedy GA; Ho PJ; Sidiqi MH; Bashford J; Routledge D; Taylor K; Lee CH; Kalff A; Xia W; Hamad N, 2020, 'Trends in Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study', Blood, 136, pp. 11 - 12, http://dx.doi.org/10.1182/blood-2020-138991

Journal articles | 2020

McCaughan GJ; Verma A; Ling S; Lavee O; Moore J; Bryant A, 2020, 'Weekly Cyclophosphamide, Subcutaneous Bortezomib and Dexamethathasone (CyBorD) for Initial Treatment of Transplant Eligible Patients with Multiple Myeloma: Experience of Two Transplant Centres', Blood, 136, pp. 42 - 43, http://dx.doi.org/10.1182/blood-2020-139269

Journal articles | 2019

Blennerhassett R; McCaughan G; Tegg E, 2019, 'Massive Splenomegaly, An Unexpected Diagnosis', Pathology, 51, pp. S41 - S41, http://dx.doi.org/10.1016/j.pathol.2018.12.091

Journal articles | 2018

Blennerhassett R; McCaughan G; Tegg E, 2018, 'An unexpected diagnosis: leukaemic presentation of blastic plasmacytoid dendritic cell neoplasm with massive splenomegaly', Pathology, 50, pp. 773 - 775, http://dx.doi.org/10.1016/j.pathol.2018.05.007

Journal articles | 2018

Favaloro EJ; McCaughan G; Mohammed S; Lau KKE; Gemmell R; Cavanaugh L; Donikian D; Kondo M; Brighton T; Pasalic L, 2018, 'HIT or miss? A comprehensive contemporary investigation of laboratory tests for heparin induced thrombocytopenia', Pathology, 50, pp. 426 - 436, http://dx.doi.org/10.1016/j.pathol.2017.11.089

Journal articles | 2018

Favaloro EJ; McCaughan GJB; Mohammed S; Pasalic L, 2018, 'Anticoagulation therapy in Australia', Annals of Blood, 3, pp. 48 - 48, http://dx.doi.org/10.21037/aob.2018.12.02

Journal articles | 2018

McCaughan GJB; Favaloro EJ; Pasalic L; Curnow J, 2018, 'Anticoagulation at the extremes of body weight: choices and dosing', Expert Review of Hematology, 11, pp. 817 - 828, http://dx.doi.org/10.1080/17474086.2018.1517040

Journal articles | 2017

Favaloro EJ; McCaughan G; Pasalic L, 2017, 'Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update', Pathology, 49, pp. 346 - 355, http://dx.doi.org/10.1016/j.pathol.2017.02.005

Journal articles | 2017

McCaughan G; Massey J; Sutton I; Curnow J, 2017, 'Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosis', BMJ Case Reports, 2017, http://dx.doi.org/10.1136/bcr-2017-223016

Journal articles | 2016

McCaughan GJB; Fulham MJ; Mahar A; Soper J; Hong AM; Stalley PD; Tattersall MHN; Bhadri VA, 2016, 'Programmed cell death-1 blockade in recurrent disseminated Ewing sarcoma', Journal of Hematology and Oncology, 9, http://dx.doi.org/10.1186/s13045-016-0278-x

Journal articles | 2013

Kiely BE; McCaughan G; Christodoulou S; Beale PJ; Grimison P; Trotman J; Tattersall MHN; Stockler MR, 2013, 'Using scenarios to explain life expectancy in advanced cancer: Attitudes of people with a cancer experience', Supportive Care in Cancer, 21, pp. 369 - 376, http://dx.doi.org/10.1007/s00520-012-1526-4

Journal articles | 2013

Mccaughan GJ; Blinman PL; Boyer MJ; Stockler MR, 2013, 'Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancer', Internal Medicine Journal, 43, pp. 424 - 429, http://dx.doi.org/10.1111/j.1445-5994.2012.02846.x

Journal articles | 2012

Stockler MR; Kiely BE; McCaughan GJ; Christodoulou S; Beale PJ; Trotman J; Grimison P; Tattersall MHN, 2012, 'Using scenarios to explain survival time: Attitudes of people with a cancer experience.', Journal of Clinical Oncology, 30, pp. 9126 - 9126, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9126
Conference Abstracts | 2024

Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; McCaughan G; Hamad N, 2024, 'A minority of women of childbearing potential are tested for pregnancy before chemoimmunotherapy: an Australian cancer centre experience', in Internal Medicine Journal, Vol. 54, pp. 750 - 754, http://dx.doi.org/10.1111/imj.16287

Conference Posters | 2024

Gorrie N; Iglesias CK; Fatkin D; Carroll AS; McCaughan G; Bart NK, 2024, 'Cardiac magnetic resonance imaging for the early diagnosis of AL cardiomyopathy: a case series', MN, Rochester, Vol. 31, pp. S182 - S182, presented at 19th International Symposium on Amyloidosis (ISA), MN, Rochester, 26 May 2024 - 30 May 2024

Conference Posters | 2024

Gorrie N; Iglesias CK; Fatkin D; Hayward C; Macdonald P; Jabbour A; Kotlyar E; Muthiah K; McCaughan G; Carroll AS; Bart NK, 2024, 'Cardiac transplantation for transthyretin amyloidosis (ATTR): a single centre experience', MN, Rochester, Vol. 31, pp. S183 - S183, presented at 19th International Symposium on Amyloidosis (ISA), MN, Rochester, 26 May 2024 - 30 May 2024

Conference Posters | 2024

Gorrie N; Iglesiasc CK; Fatkin D; McCaughan G; Bart NK; Carroll A, 2024, 'Diagnosing transthyretin amyloidosis: a single centre experience with histopathological diagnosis', MN, Rochester, Vol. 31, pp. S238 - S238, presented at 19th International Symposium on Amyloidosis (ISA), MN, Rochester, 26 May 2024 - 30 May 2024

Conference Posters | 2024

Montgomery E; Gorrie N; Rye E; Iglesias CK; Fatkin D; Macdonald P; Carroll AS; McCaughan G; Bart NK, 2024, 'The prevalence of frailty and association with disease severity in transthyretin amyloid cardiomyopathy', MN, Rochester, Vol. 31, pp. S106 - S106, presented at 19th International Symposium on Amyloidosis (ISA), MN, Rochester, 26 May 2024 - 30 May 2024

Conference Abstracts | 2023

Bryant C; Abadir E; Doo NW; Bryant A; McCaughan G; Yang S; Vanguru V; King T; Joshua D; Ho PJ, 2023, 'P-070 Failure to clear circulating tumor cells after one week of daratumumab, bortezomib and dexamethasone is associated with a reduced progression-free survival for myeloma patients', in Clinical Lymphoma Myeloma and Leukemia, Elsevier BV, Vol. 23, pp. S73 - S73, http://dx.doi.org/10.1016/s2152-2650(23)01688-9

Conference Abstracts | 2023

Corr A; Chai R; Khoo WH; McCaughan G; Ren Q; Smith J; Roden D; Cazet A; Chan C-L; Stewart S; Swarbrick A; Moore J; Baldock P; Phan TG; Croucher P, 2023, 'Single-Cell Ligand-Receptor Analysis Identifies Dormant Tumour Cell Control Pathways in the Skeleton', in JOURNAL OF BONE AND MINERAL RESEARCH, WILEY, Vol. 38, pp. 55 - 55

Conference Abstracts | 2022

Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; McCaughan G; Moore J; Hamad N; Hurwitz J, 2022, 'Rates of contraceptive uptake and documentation of discussion with anticancer therapy: Women deserve gender specific care', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 209 - 209

Conference Abstracts | 2022

Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; McCaughan G; Moore J; Hamad N; Hurwitz J, 2022, 'Rates of fertility discussions and counselling before, during and after anticancer treatments: Women deserve gender specific care', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 175 - 175

Conference Abstracts | 2022

Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; Moore J; McCaughan G; Hamad N; Hurwitz J, 2022, 'Rate of menstruation history taking and counselling before, during and after anticancer treatments', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 174 - 175

Conference Abstracts | 2022

Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rogers R; Lavee O; Milliken S; McCaughan G; Moore J; Hamad N; Hurwitz J, 2022, 'Rates of sexual history taking and sexual dysfunction counselling with cancer care', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 175 - 176

Conference Abstracts | 2022

Gorrie N; McCaughan G; Carroll A; Jabbour A; Kotlyar E; Fatkin D; Bart N, 2022, 'Role of Endomyocardial Biopsy and Mass Spectrometry for Precision in Cardiac Amyloid Subtyping: A Case Series', in Heart, Lung and Circulation, Elsevier BV, Vol. 31, pp. S99 - S100, http://dx.doi.org/10.1016/j.hlc.2022.06.123

Conference Papers | 2022

Lasica M; Spencer A; Campbell P; Wallington-Gates C; Doo NW; Janowski W; McCaughan G; Puliyayil A; Yuen F; Le K; Reynolds J; Quach H, 2022, 'An interim analysis of a phase I/II single arm study of belantamab mafodotin, carfilzomib and dexamethasone in patients with relapsed multiple myeloma: AMaRC 19-02 BelaCarD study', in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, CIG MEDIA GROUP, LP, pp. S29 - S30

Conference Abstracts | 2021

Quach H; Lasica M; Routledge D; Kalff A; Lim A; Low M; Estell JA; Sidiqi MH; Campbell P; Eek RW; Lai HC; McCaughan GJ; D'Rozario J; Browlett P; Rajagopal R; Heenan J; Murphy NE; Renwick W; Huan G; Mollee P, 2021, 'A randomized, open-label, phase 3 study of low-dose selinexor and lenalidomide (Len) versus len maintenance post autologous stem cell transplant (ASCT) for newly diagnosed multiple myeloma (NDMM): ALLG MM23, Sealand.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, Vol. 39, presented at Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 04 June 2021 - 08 June 2021, http://dx.doi.org/10.1200/JCO.2021.39.15_suppl.TPS8055

Conference Abstracts | 2020

McCaughan GJ; Tran S; Durrant S; Harrison SJ; Morton J; Horvath N; Spencer A; Kerridge IH; Er JAK; Barge L; Bryant A; Filshie RJ; Choong E; Lai HC; Tiley C; Mills AK; Butler A; Moore J; Hertzberg M; Kennedy GA; Ho PJ; Sidiqi MH; Bashford J; Routledge D; Taylor K; Lee CH; Kalff A; Xia W; Hamad N, 2020, 'Trends in Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study', in BLOOD, AMER SOC HEMATOLOGY, Vol. 136, http://dx.doi.org/10.1182/blood-2020-138991

Conference Abstracts | 2020

McCaughan GJ; Verma A; Ling S; Lavee O; Moore J; Bryant A, 2020, 'Weekly Cyclophosphamide, Subcutaneous Bortezomib and Dexamethathasone (CyBorD) for Initial Treatment of Transplant Eligible Patients with Multiple Myeloma: Experience of Two Transplant Centres', in Blood, American Society of Hematology, Vol. 136, pp. 42 - 43, http://dx.doi.org/10.1182/blood-2020-139269

Conference Papers | 2011

Kiely BE; McCaughan G; Christodoulou S; Tattersall MHN; Beale P; Grimison P; Stockler MR, 2011, 'Patients' Views about How Oncologists Should Explain Prognosis in Advanced Cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, http://dx.doi.org/10.1158/0008-5472.SABCS11-P5-15-02

Follow

Miss Georgia McCaughan